The DDR pathways, particularly the CGAS-STING1 pathway, have been targeted, mostly through genetic and to a lesser degree through pharmacological interventions, in mouse models of cardiovascular diseases (Table 1). The gene discussed is STING1; the disease is cardiovascular disorder.